Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsDivislaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Sell Jubilant Food; buy Divis Labs, GSK Consumer: Experts

      SP Tulsian of sptulsian.com says GlaxoSmithKline Consumer Healthcare looks a good short-term buy. "Probably in the month of July, we will be able to see a price of Rs 5000-5200," he adds.

    • Buy Siemens, Apollo Hospitals, MphasiS: Saurabh Mittal

      Saurabh Mittal of Swadeshi Capital is bullish on Siemens, Apollo Hospitals and MphasiS. However, he keeps sell rating on Divis Laboratories.

    • Bull's Eye: Buy JM Financial, Siemens, Bharat Forge

      SP Tulsian of sptulsian.com advised buying JM Financial with a target price of Rs 28 and GSPL with a target price of Rs 61.

    • Short Axis Bank, Divis Laboratories: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that, one can short Axis Bank and Divis Laboratories at current levels.

    • Dr Reddy's Lab top pick in pharma: IIFL Capital

      Bino Pathiparampil of IIFL Capital told CNBC-TV18 that there has been a major rally in the sector over the last couple of years. Thus, many of the stocks went up 20 percent in the last couple of months itself.

    • Expect more weakness in Divis Laboratories: Joshi

      Sharmila Joshi, Head of Equity of Peerless Securities expects more weakness in Divis Laboratories. The stock may lose another 3-4 percent from here on.

    • Sell IFCI, Voltas, Divis Laboratories: Tater

      Aashish Tater of FortuneWizard.com is bearish on IFCI, Voltas and Divis Laboratories. He recommended selling these stocks.

    • Bull's Eye: Short IFCI; buy Thomas Cook, Aditya Birla Nuvo

      Aashish Tater of FortuneWizard.com advised going long in Crompton Greaves with a target price of Rs 106 and going short in Divis Labs with a target price of Rs 1040.

    • Buy Divis Labs, UCO Bank, Zee Ent: Parag Doctor

      Parag Doctor of Keynote Capital is bullish on Divis Laboratories, UCO Bank, Zee Entertainment and has recommended buy rating on the stocks, while he maintained sell rating on Opto Circuits India.

    • See higher levels in Ranbaxy, says Sukhani

      Sudarshan Sukhani of s2analytics.com feels that a new uptrend seems to be starting in Ranbaxy Laboratories.

    • Bull's eye: Buy Sonata Soft, UCO Bank, RCom; sell Dabur

      SP Tulsian of sptulsian.com has recommended buy rating on Sun Pharma Advanced Research Company, Autoline Industries, Sonata Software and Reliance Communications.

    • Go long in Divis Laboratories: Sukhani

      One can take a long position in Divis Laboratories. It is likely to outperform, says Sudarshan Sukhani of s2analytics.com.

    • Buy Tata Global, Divis Labs, Rallis India: Merani

      In CNBC-TV18's popular show Bull's Eye, Nooresh Merani of AMSEC Research shares his trading strategies for the day.

    • Bull's Eye: Buy Bank of Maha, Jet, Kolte-Patil, Tata Global

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Buy Tata Global, Divis Labs, Bombay Burmah: Merani

      In CNBC-TV18's popular show Bull's Eye, Nooresh Merani, AMSEC Research shares his trading strategies for the day.

    • Bull's Eye: Buy Tata Global, SpiceJet, Bombay Burmah

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Buy Divis Laboratories, says Sukhani

      Sudarshan Sukhani of s2analytics.com advised buying Divis Laboratories. According to him, pharmaceutical sector still outperforms.

    • Prefer Glenmark Pharma, Biocon over Divis Lab: SP Tulsian

      SP Tulsian, sptulsian.com advises to prefer Glenmark Pharma and Biocon over Divis Lab.

    • Buy Andhra Bank, Mahindra Satyam, Tata Global: Kapur

      In CNBC-TV18's popular show Bull's Eye, Ashish Kapur of Investshoppe shares trading strategy of the day.

    • Bull's Eye: Buy PTC, YES Bank, Cairn, Tata Global

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Buy Godrej Ind, Raymond, Fresenius Kabi: Merani

      In CNBC-TV18's popular show Bull's Eye, Nooresh Merani, AMSEC Research shares trading strategy of the day.

    • Check out: Top stock ideas by top market experts

      In an interview to CNBC-TV18, Sudarshan Sukhani of s2analytics.com, SP Tulsian of sptulsian.com and VK Sharma, HDFC Securities give top pick for the day.

    • Bull's eye: Buy NMDC, IOC, Raymond, Kwality Dairy

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Divis Labs may move up to Rs 1,095-1,115: Manghnani

      According to Anil Manghnani of Modern Shares & Stock Brokers, Divis Labs should head a little bit higher. It may move to Rs 1,095-1,115 levels, he adds.

    • Check out: Trading ideas from 3 market experts

      In an interview to CNBC-TV18, SP Tulsian of sptulsian.com, Sudarshan Sukhani of s2analytics.com and Hemant Thukral give top pick for the day.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347